Skip to main content

Table 2 Secondary endpoints

From: Randomized controlled phase I/II study to investigate immune stimulatory effects by low dose radiotherapy in primarily operable pancreatic cancer

   • Local control and recurrence patterns of pancreatic cancer

   • Progression free survival

   • Radiation related toxicity

   • Surgical morbidity in patients who received this protocol treatment

   • 30 day postoperative mortality

   • Quality of life according to EORTC QoL questionnaire after 3 and 6 months

   • Plasma proteomics

   • Whole blood transcriptomics

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us